window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 19, 2025

  • News
  • About Us
Contact Us

Editor’s Choice

  • Cell & Gene Therapy,European biotech,Movers & Shakers

    Atelerix appoints new chair and non-executive director to board

    Atelerix, a Newcastle-based biotech specialising in hydrogel encapsulation for cell [...]

    August 12, 2025
  • CDMOs & Manufacturing,Movers & Shakers

    Aragen appoints Aniel Khubchandani to lead development and manufacturing solutions business

    Contract research, development and manufacturing organisation Aragen has appointed Aniel [...]

    August 7, 2025
  • CDMOs & Manufacturing,Movers & Shakers

    Christian Dowdeswell named managing director at Arcinova

    Arcinova, a UK-based Contract Research Development and Manufacturing Organisation (CRDMO) [...]

    August 6, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Movers & Shakers,Research & Development

    Meitheal strengthens leadership team with new chief medical officer and head of medical affairs

    Appointments reflect strategic focus on infectious disease and medical affairs [...]

    August 1, 2025
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Movers & Shakers,Oncology,Precision medicine

    PhoreMost appoints Pfizer drug discovery veteran Dr Adam Gilbert to scientific advisory board

    Appointment strengthens expertise in targeted protein degradation as company advances [...]

    July 28, 2025
  • CDMOs & Manufacturing,Drug Development,Movers & Shakers

    Abzena appoints Geoffrey Glass as CEO to drive next growth phase

    Abzena, the integrated CDMO and CRO specializing in complex biologics [...]

    July 22, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy

    Innovations driving efficient adherent cell cultivation in biotech

    Scaling adherent cell culture from early-stage research to commercial manufacturing [...]

    July 10, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development

    Shift Bioscience tackles AI model flaws to advance rejuvenation discovery

    New study proposes AI-driven framework to refine gene target discovery [...]

    July 4, 2025
  • Artificial Intelligence,Market Access & Commercialization,Oncology

    Caris CMO on AI, equity, and the future of multi-omic oncology

    The former ASCO president shares his insights on breast cancer [...]

    July 4, 2025
  • Artificial Intelligence,Technology and platforms

    PharmaForceIQ reports strong growth as demand for optichannel strategies rises

    PharmaForceIQ, an independent provider of precision customer engagement technologies for [...]

    July 1, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaxCyte signs platform licence with Moonlight Bio to advance T cell therapies for solid tumours
    Categories: Biotech, Cell & Gene Therapy, Partnerships & Funding, Research & Development
  • Nordic Life Science Days 2025 opens in Gothenburg with calls for deeper collaboration and global investment
    Categories: European biotech, Events and Conferences, Global health, Healthcare leadership, Market Access & Commercialization, Partnerships & Funding, Research & Development
  • New AI tool offers real-time insights into clinical trial participant behavior
    Categories: Artificial Intelligence, Clinical Development, Digital Health, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top